Neurodiagnostic and Monitoring Devices Market in US 2024-2028

The neurodiagnostic and monitoring devices market in US is forecasted to grow by USD 827.88 mn during 2023-2028, accelerating at a CAGR of 6.19% during the forecast period. The report on the neurodiagnostic and monitoring devices market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidences and prevalence of neurological conditions, growing demand for eeg procedures, and increasing initiatives and support from governments and healthcare organizations.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.24%
CAGR	6.19%
Incremental Value	$827.88mn

Technavio's neurodiagnostic and monitoring devices market in US is segmented as below:

By Product

ICP Monitoring devices
EEG devices
EMG devices
Others

By End-user

Hospitals
Clinics
Laboratories

By Application

Stroke
Migraine
Epilepsy
Parkinsons disease
Ischemic stroke

This study identifies the technological advances in neurodiagnostic and monitoring devices as one of the prime reasons driving the neurodiagnostic and monitoring devices market in US growth during the next few years. Also, initiatives to promote neurodiagnostic and monitoring devices and paradigm shift toward hybrid brain-computer interface will lead to sizable demand in the market.

The report on the neurodiagnostic and monitoring devices market in US covers the following areas:

Neurodiagnostic and monitoring devices market in US sizing
Neurodiagnostic and monitoring devices market in US forecast
Neurodiagnostic and monitoring devices market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurodiagnostic and monitoring devices market in US vendors that include Advanced Brain Monitoring Inc., Ambu AS, Bio Signal Group Corp., Cadwell Industries Inc., Compumedics Ltd., Delsys Inc., ELMIKO BIOSIGNALS sp. z o.o., General Electric Co., Jordan NeuroScience, Koninklijke Philips N.V., Lifelines Neuro Company LLC, Masimo Corp., Medtronic Plc, Motion Lab Systems Inc, Natus Medical Inc., neurocare group AG, Nihon Kohden Corp., NovaSignal Corp., RAUMEDIC AG, and Viasonix Ltd. Also, the neurodiagnostic and monitoring devices market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40602

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Product
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 12: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 13: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 14: Chart on US: Year-over-year growth 2023-2028 (%)
Exhibit 15: Data Table on US: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Neurodiagnostic and monitoring devices market in US 2018 - 2022
Exhibit 16: Historic Market Size - Data Table on neurodiagnostic and monitoring devices market in US 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 17: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 18: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 27: Chart on Product - Market share 2023-2028 (%)
Exhibit 28: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 29: Chart on Comparison by Product
Exhibit 30: Data Table on Comparison by Product
6.3 ICP Monitoring devices - Market size and forecast 2023-2028
Exhibit 31: Chart on ICP Monitoring devices - Market size and forecast 2023-2028 ($ million)
Exhibit 32: Data Table on ICP Monitoring devices - Market size and forecast 2023-2028 ($ million)
Exhibit 33: Chart on ICP Monitoring devices - Year-over-year growth 2023-2028 (%)
Exhibit 34: Data Table on ICP Monitoring devices - Year-over-year growth 2023-2028 (%)
6.4 EEG devices - Market size and forecast 2023-2028
Exhibit 35: Chart on EEG devices - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Data Table on EEG devices - Market size and forecast 2023-2028 ($ million)
Exhibit 37: Chart on EEG devices - Year-over-year growth 2023-2028 (%)
Exhibit 38: Data Table on EEG devices - Year-over-year growth 2023-2028 (%)
6.5 EMG devices - Market size and forecast 2023-2028
Exhibit 39: Chart on EMG devices - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Data Table on EMG devices - Market size and forecast 2023-2028 ($ million)
Exhibit 41: Chart on EMG devices - Year-over-year growth 2023-2028 (%)
Exhibit 42: Data Table on EMG devices - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 43: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 45: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 46: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Exhibit 47: Market opportunity by Product ($ million)
Exhibit 48: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 49: Chart on End-user - Market share 2023-2028 (%)
Exhibit 50: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 51: Chart on Comparison by End-user
Exhibit 52: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 53: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 55: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 56: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Clinics - Market size and forecast 2023-2028
Exhibit 57: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 59: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 60: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
7.5 Laboratories - Market size and forecast 2023-2028
Exhibit 61: Chart on Laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Data Table on Laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 63: Chart on Laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 64: Data Table on Laboratories - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 65: Market opportunity by End-user ($ million)
Exhibit 66: Data Table on Market opportunity by End-user ($ million)

8 Market Segmentation by Application

8.1 Market segments
Exhibit 67: Chart on Application - Market share 2023-2028 (%)
Exhibit 68: Data Table on Application - Market share 2023-2028 (%)
8.2 Comparison by Application
Exhibit 69: Chart on Comparison by Application
Exhibit 70: Data Table on Comparison by Application
8.3 Stroke - Market size and forecast 2023-2028
Exhibit 71: Chart on Stroke - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Stroke - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Stroke - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Stroke - Year-over-year growth 2023-2028 (%)
8.4 Migraine - Market size and forecast 2023-2028
Exhibit 75: Chart on Migraine - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Migraine - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Migraine - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Migraine - Year-over-year growth 2023-2028 (%)
8.5 Epilepsy - Market size and forecast 2023-2028
Exhibit 79: Chart on Epilepsy - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Epilepsy - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Epilepsy - Year-over-year growth 2023-2028 (%)
8.6 Parkinsons disease - Market size and forecast 2023-2028
Exhibit 83: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
8.7 Ischemic stroke - Market size and forecast 2023-2028
Exhibit 87: Chart on Ischemic stroke - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Ischemic stroke - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Ischemic stroke - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Ischemic stroke - Year-over-year growth 2023-2028 (%)
8.8 Market opportunity by Application
Exhibit 91: Market opportunity by Application ($ million)
Exhibit 92: Data Table on Market opportunity by Application ($ million)

9 Customer Landscape

9.1 Customer landscape overview
Exhibit 93: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 94: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 95: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 96: Overview on factors of disruption
11.4 Industry risks
Exhibit 97: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 98: Vendors covered
12.2 Market positioning of vendors
Exhibit 99: Matrix on vendor position and classification
12.3 Advanced Brain Monitoring Inc.
Exhibit 100: Advanced Brain Monitoring Inc. - Overview
Exhibit 101: Advanced Brain Monitoring Inc. - Key offerings
12.4 Ambu AS
Exhibit 102: Ambu AS - Overview
Exhibit 103: Ambu AS - Business segments
Exhibit 104: Ambu AS - Key offerings
Exhibit 105: Ambu AS - Segment focus
12.5 Bio Signal Group Corp.
Exhibit 106: Bio Signal Group Corp. - Overview
Exhibit 107: Bio Signal Group Corp. - Product / Service
Exhibit 108: Bio Signal Group Corp. - Key offerings
12.6 Cadwell Industries Inc.
Exhibit 109: Cadwell Industries Inc. - Overview
Exhibit 110: Cadwell Industries Inc. - Product / Service
Exhibit 111: Cadwell Industries Inc. - Key offerings
12.7 Compumedics Ltd.
Exhibit 112: Compumedics Ltd. - Overview
Exhibit 113: Compumedics Ltd. - Product / Service
Exhibit 114: Compumedics Ltd. - Key offerings
12.8 Delsys Inc.
Exhibit 115: Delsys Inc. - Overview
Exhibit 116: Delsys Inc. - Product / Service
Exhibit 117: Delsys Inc. - Key offerings
12.9 ELMIKO BIOSIGNALS sp. z o.o.
Exhibit 118: ELMIKO BIOSIGNALS sp. z o.o. - Overview
Exhibit 119: ELMIKO BIOSIGNALS sp. z o.o. - Product / Service
Exhibit 120: ELMIKO BIOSIGNALS sp. z o.o. - Key offerings
12.10 General Electric Co.
Exhibit 121: General Electric Co. - Overview
Exhibit 122: General Electric Co. - Business segments
Exhibit 123: General Electric Co. - Key news
Exhibit 124: General Electric Co. - Key offerings
Exhibit 125: General Electric Co. - Segment focus
12.11 Koninklijke Philips N.V.
Exhibit 126: Koninklijke Philips N.V. - Overview
Exhibit 127: Koninklijke Philips N.V. - Business segments
Exhibit 128: Koninklijke Philips N.V. - Key news
Exhibit 129: Koninklijke Philips N.V. - Key offerings
Exhibit 130: Koninklijke Philips N.V. - Segment focus
12.12 Lifelines Neuro Company LLC
Exhibit 131: Lifelines Neuro Company LLC - Overview
Exhibit 132: Lifelines Neuro Company LLC - Product / Service
Exhibit 133: Lifelines Neuro Company LLC - Key offerings
12.13 Masimo Corp.
Exhibit 134: Masimo Corp. - Overview
Exhibit 135: Masimo Corp. - Product / Service
Exhibit 136: Masimo Corp. - Key offerings
12.14 Medtronic Plc
Exhibit 137: Medtronic Plc - Overview
Exhibit 138: Medtronic Plc - Business segments
Exhibit 139: Medtronic Plc - Key news
Exhibit 140: Medtronic Plc - Key offerings
Exhibit 141: Medtronic Plc - Segment focus
12.15 Natus Medical Inc.
Exhibit 142: Natus Medical Inc. - Overview
Exhibit 143: Natus Medical Inc. - Product / Service
Exhibit 144: Natus Medical Inc. - Key news
Exhibit 145: Natus Medical Inc. - Key offerings
12.16 Nihon Kohden Corp.
Exhibit 146: Nihon Kohden Corp. - Overview
Exhibit 147: Nihon Kohden Corp. - Product / Service
Exhibit 148: Nihon Kohden Corp. - Key news
Exhibit 149: Nihon Kohden Corp. - Key offerings
12.17 Viasonix Ltd
Exhibit 150: Viasonix Ltd - Overview
Exhibit 151: Viasonix Ltd - Product / Service
Exhibit 152: Viasonix Ltd - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 153: Inclusions checklist
Exhibit 154: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 155: Currency conversion rates for US$
13.4 Research methodology
Exhibit 156: Research methodology
Exhibit 157: Validation techniques employed for market sizing
Exhibit 158: Information sources
13.5 List of abbreviations
Exhibit 159: List of abbreviations